Trial Profile
Study on the Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Rituximab (Primary)
- Indications Hairy cell leukaemia
- Focus Therapeutic Use
- 15 Jul 2014 New trial record